Cautious notification and continual monitoring of patients with mild cognitive impairment

Toshinari Odawara1

  • 1Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan. odawara@yokohamacu.ac.jp

Insights

Mild cognitive impairment (MCI) requires careful communication to avoid patient distress. Current interventions lack confirmed efficacy, making monitoring and lifestyle guidance key strategies.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) signifies a decline from previous cognitive function, falling between normal aging and dementia.
  • MCI patients do not invariably progress to dementia, necessitating cautious communication regarding their diagnosis.
  • Current therapeutic strategies for MCI, including pharmacotherapy and cognitive training, have not demonstrated confirmed efficacy in preventing dementia.

Purpose of the Study:

  • To emphasize the importance of cautious communication when informing patients about mild cognitive impairment.
  • To review the current evidence regarding the efficacy of interventions for MCI.
  • To propose an appropriate management strategy for patients with MCI.

Main Methods:

  • This study is a review of current literature and clinical understanding of mild cognitive impairment.
  • Analysis of communication strategies and their psychological impact on patients diagnosed with MCI.
  • Evaluation of the evidence base for pharmacotherapy and non-pharmacotherapy interventions in MCI.

Main Results:

  • Inappropriate notification of MCI can induce anxiety and the misconception of inevitable dementia progression.
  • No specific interventions, pharmacological or non-pharmacological, are currently proven to prevent dementia in MCI patients.
  • The efficacy of cognitive function training and other therapies remains unconfirmed for MCI management.

Conclusions:

  • Careful, personalized communication is crucial when diagnosing and discussing mild cognitive impairment with patients.
  • Periodic patient monitoring, lifestyle guidance, and management of related diseases are recommended as the current appropriate strategy for MCI.
  • Further research is needed to establish effective interventions for preventing dementia progression in individuals with MCI.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...